Clinical Trials Browser

Non-Muscle Invasive Bladder Neoplasms × Antibodies × Genitourinary × Clear all

NCT05259397 2023-03-08

PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Phase 1 Withdrawn

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms